Genmab — December 2017
-
Bekymrende at den falder på relativ stor omsætning.
-
OHW...du får nok ret...970 inden jul.
-
Nu har der været 3 handelsdage i rap med volumen over 1% af aktierne - fortsætter vi meget længere, vil alle ejerne blive skiftet ud...
-
Det var dog en uhyggelig tank
e...:-( -
så er der da virklig` no hope..
-
-
Ny artikel om Hexabody: van der Horst, H. J., Overdijk, M. B., Breij, E. C., Chamuleau, M., Lokhorst, H. M., & Mutis, T. (2017). Potent Ex Vivo Anti-Tumor Activity in Relapsed Refractory Multiple Myeloma Using Novel DR5-Specific Antibodies with Enhanced Capacity to Form Hexamers upon Target Binding. Blood, 130(Suppl 1), 1835.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
